Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 09:49
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Salem's -14.33% gross margin accelerated to, up from -275.81%.
The company's .81% marginal operating leverage is decelerating. Salem's .4% revenue growth is declining. The . Salem's .29 INR close price remained flat.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | -14.33 % | -275.81 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -275.81 % | 0 | ▼ |
| REVENUE_GROWTH_YOY | -32.4 % | — | - |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 40 shares | 3,232 | ▼ |
| CLOSE_PRICE | 19.29 INR | 19.29 | - |
Cite this
Source: Samhati evidence synthesis for SALEM (2026-10-21). Observation: Salem's -14.33% gross margin accelerated to, up from -275.81%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/salem
Filing step-changes